Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Network Pharmacology-based Personalized Drug Repurposing in Thyroid Carcinoma: a Pilot Feasibility Trial

NCT07485569 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT07485569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07485569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Network Pharmacology-based Personalized Drug Repurposing in Thyroid Carcinoma: a Pilot Feasibility Trial
Lead sponsor
Radboud University Medical Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
August 1, 2026
Completion date
December 1, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic thyroid cancer, differentiated thyroid cancer, poorly differentiated thyroid carcinoma, thyroid cancer stage iv